血素固定化血液相容的放射性不透明聚氨微球用于局部血液凝固
Sonali S Naik1,2, Arun Torris1, Gorakh Hiraman Ghuge1,2
1Polymer Science and Engineering Division, CSIR-National Chemical Laboratory, Pune, India.
新的放射性不透明微球通过允许非侵入性监测和增强血液静止来改善栓塞治疗. 凝血素固定提供独特的辐射透明度和静血性质,以提高栓塞效率.
科学领域:
- 生物材料科学 生物材料科学
- 干预性放射学 干预性放射学
- 聚合物化学 聚合物化学
背景情况:
- 微球越来越多地用于栓塞,但诸如非侵入性监测和反流引起的并发症等挑战仍然存在.
- 目前的栓塞剂缺乏固有的放射性透明性,这阻碍了在手术过程中实时跟踪.
- 由于反流而导致的无意闭塞限制了栓塞治疗的安全性和有效性.
研究的目的:
- 为改进栓塞程序开发新型无辐射微球.
- 解决当前栓塞剂的局限性,包括可追溯性差和反流风险.
- 为了创建具有增强血静性质和非侵入性监测能力的微球.
主要方法:
- 一种有的单体 (IBHV) 的合成,用于放射透明性和功能性.
- 制造放射性不透明的聚氨微球 (平均直径474±73微米).
- 将血栓素固定在微球表面,以增强静血效应.
主要成果:
- 成功合成IBHV并制造了光滑表面,无线电透的微球.
- 微球显示出非细胞毒性和可接受的血解率.
- 通过X射线成像提高了可追溯性,在血栓固定后改善了静血效应.
结论:
- 开发了具有内在辐射透明度和表面功能的特殊微球,用于栓塞.
- 凝血素固定微球提供增强的静血和可追溯性,提高栓塞效率.
- 这些进展为更安全,更有效的栓塞疗法铺平了道路.
更多相关视频
10:50Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging
Published on: June 29, 2013
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Clot Retraction and Fibrinolysis
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
